Epitomee Medical Ltd
TLV: EPIT.TA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tel Aviv Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Radan Hashimshony
- Employees
- 42
- Headquarters
- Caesarea, Israel
- IPO year
- 2021
- Market cap
- ILA 241.5M
- Website
- https://www.epitomeemedical.com
Loading EPIT…
Loading profile data…Frequently asked questions about EPIT
What does Epitomee Medical Ltd (EPIT.TA) do?
Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide. Its capsule is used for weight management, waist circumference reduction, and cardiovascular risk factors reduction. Epitomee Medical Ltd has a strategic partnership with Nestlé Health Science S.A. for the development and commerciali...
Where does EPIT.TA trade?
Epitomee Medical Ltd (EPIT.TA) trades on the Tel Aviv Stock Exchange.
What sector is EPIT.TA in?
Epitomee Medical Ltd (EPIT.TA) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Epitomee Medical Ltd?
Radan Hashimshony is the chief executive officer of Epitomee Medical Ltd (EPIT.TA).
Where is Epitomee Medical Ltd headquartered?
Epitomee Medical Ltd is headquartered in Israel.
Does EPIT.TA pay a dividend?
Epitomee Medical Ltd (EPIT.TA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EPIT.TA go public?
Epitomee Medical Ltd (EPIT.TA) completed its initial public offering in 2021.